Inventor · disambiguated record
Clifford David Jones
Also filed as: JONES CLIFFORD · JONES CLIFFORD D · JONES CLIFFORD DAVID
14 granted patents·22 pending applications·90 citations·filing 2002–2023
90Inventor score
Files withASTRAZENECA AB17JAZZ PHARMACEUTICALS IRELAND LTD6REDX PHARMA PLC5ANDREWS DAVID3REDX PHARMA LTD2
Top patents by PatentIndex Score
36 records- 0196US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 0290US7390908B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2002·Granted Jun 24, 2008·33 cites·19 claims
- 0389US11878020B2Modulators of Rho-associated protein kinaseREDX PHARMA PLC·Filed 2022·Granted Jan 23, 2024·1 cites·20 claims
- 0485US8569298B2Pyridine compoundsBARLAAM BERNARD CHRISTOPHE·Filed 2009·Granted Oct 29, 2013·11 cites·17 claims
- 0584US11497751B2Modulators of Rho-associated protein kinaseREDX PHARMA PLC·Filed 2019·Granted Nov 15, 2022·5 cites·25 claims
- 0682US12453734B2Modulators of rho-associated protein kinaseREDX PHARMA LTD·Filed 2023·Granted Oct 28, 2025·0 cites·10 claims
- 0781US11858930B2Fused bicyclic RAF inhibitors and methods for use thereofJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2021·Granted Jan 2, 2024·1 cites·17 claims
- 0877US9902731B2Chemical compoundsASTRAZENECA AB·Filed 2016·Granted Feb 27, 2018·2 cites·19 claims
- 0976US12304912B2Fused bicyclic RAF inhibitors and methods for use thereofJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2023·Granted May 20, 2025·0 cites·18 claims
- 1073US7951830B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2009·Granted May 31, 2011·1 cites·11 claims
- 1172US7745428B2Imidazo[1,2-A]pyridine having anti-cell-proliferation activityASTRAZENECA AB·Filed 2006·Granted Jun 29, 2010·2 cites·14 claims
- 1264US7427616B2Condensed pyridines and pyrimidines with tie2 (TEK) activityASTRAZENECA AB·Filed 2003·Granted Sep 23, 2008·3 cites·18 claims
- 1360US2025122173A1Modulators of rho-associated protein kinaseREDX PHARMA LTD·Filed 2023·Application pending·0 cites
- 1459US2024279241A1Pyrido[4,3-d]pyrimidine compounds capable of inhibiting kras mutant proteinsREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1559US2025197407A1Tricyclic phthalazines and derivatives as sos1 inhibitorsJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1659US2025154147A1Novel amine-substituted phthalazines and derivatives as sos1 inhibitorsJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1758US2024287078A1Quinazoline derivatives useful as ras inhibitorsREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1857US2024336592A1Phenyl- and pyridopyrazole derivatives as inhibitors of ddr1REDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1957US2007112040A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2056US2022041595A1Chiral synthesis of fused bicyclic raf inhibitorsJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 2155US10202391B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Feb 12, 2019·0 cites·3 claims
- 2251US2010105655A1Novel compounds 515ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2349US7476677B2Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of Tie2ASTRAZENECA AB·Filed 2005·Granted Jan 13, 2009·0 cites·6 claims
- 2448US2011118238A12-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disordersASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2548US2023339910A1Ras inhibitors and methods of using the sameJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 2647US2008027076A1Pyrimidines With Tie2 (Tek) ActivityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2747US2008108608A1Pyrimidines With Tie2 (Tek) ActivityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2845US2004214868A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsFiled 2002·Application pending·0 cites
- 2944US2010240686A1Chemical compoundsJONES CLIFFORD·Filed 2007·Application pending·0 cites
- 3042US2008153838A1Compounds Having Tie2 (Tek) ActivityASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3142US2008146599A1Pyrimidine Compounds Having Tie-2 (Tek) Inhibitory ActivityASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3242US2010048543A1Pyrimidine compounds having ties (tek) inhibitory activityASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3342US2008194552A1Aminopyrimidine Derivatives With Tie2 Inhibiting ActivityASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3441US2008280906A1Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative DisordersANDREWS DAVID·Filed 2006·Application pending·0 cites
- 3539US2009099160A14-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK InhibitorsANDREWS DAVID·Filed 2005·Application pending·0 cites
- 3639US2009233928A1Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferationANDREWS DAVID·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clifford David Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →